Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara

New Protocol: Polatuzumab-R-CHP for DLBCL

New Protocol: Polatuzumab-R-CHP for DLBCL
  • Double-blind Phase III trial
  • Untreated intermediate-risk or high-risk DLBCL
  • Polatuzumab-R-CHP vs R-CHOP
  • 2 years PFS: 76.7% vs 70.2% (HR:0.73 95% Cl 0.57-0.95 p=0.02)
  • 2 years OS: 88.7% vs 88.6% (HR:0.94 95% Cl 0.65-1.37 p=0.75)
  • Any grades AEs: All 97.9% vs 98.4%,
  • Grade >=3 AEs: 60.7% vs 59.8%
  • Serious AEs:34.0% vs 30.6%
  • Grade 5 AEs: 3.0% vs 2.3%

N Engl J Med. 2022;386:351-63.

Tilly H, et al. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Reviewed by Hasan Cagri Yildirim, MD on Sep 30, 2021

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More